U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Golden Caviar Skin Care - 456827 - 06/27/2018
  1. Warning Letters

CLOSEOUT LETTER

Golden Caviar Skin Care MARCS-CMS 456827 —


Recipient:
Golden Caviar Skin Care

United States

Issuing Office:

United States


 

   

Black HHS-Blue FDA Logo

 

 

 
5001 Campus Drive
College Park, MD 20740 

June 27, 2018

Pooneh Manshadi
Golden Caviar Skin Care
18732 Via Verona
Irvine, CA 92603-3441

Dear Ms. Manshadi:

The Food and Drug Administration (FDA) has completed an evaluation of your firm's corrective actions in response to our Warning Letter #456827, issued July 13, 2015. Based on our evaluation, it appears you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
 

Sincerely,
/S/

Carrie Lawlor
Acting Branch Chief
Dietary Supplement and Labeling Assessment Branch
Division of Enforcement 

 
Back to Top